SUNUM researchers' patent was also registered in the USA

Home > News > SUNUM researchers' patent was also registered in the USA

We are happy to share that the US patent application for the invention of "Immuno-Optomagnetic Point-Of-Care Assay, Method And Kit For Detection Of Analyte Using Multi-Functional Optomagnetic Quantum Dot Nanocrystals (Mqds)", which is one of the studies conducted at SUNUM, has been registered as of March 7. 

The nano-bisensor kit, which offers an easy-to-use and fast cancer screening alternative and developed as a point-of-care (PoC) diagnostic kit, stands out as a sensitive, fast and cost-effective analysis method and a promising approach for monitoring recurrent diseases such as cancer. Developed by SUNUM researchers Javed Kolkar and Anjum Qureshi, the immuno-optomagnetic PoC kit is a candidate for an easy-to-use and rapid cancer screening tool that paves the way for early detection of cancer or monitoring of cancer disease progression at the bedside or in clinical laboratories.

The PoC-based disease diagnosis method is not limited to the detection of protein biomarkers. A range of target analytes can also be detected using sample sources such as blood, urine, saliva or sweat, including other biomarkers, bacterial/viral infections, nucleic acids (DNA/RNA), drugs, chemicals, pesticides or environmental agents. Thanks to these features, it is thought that the kit will have a very wide usage area.